GWP GW Pharm.

RNS Number:2149Y
GW Pharmaceuticals PLC
10 February 2006



Embargoed until 0700                                            10 February 2006

                             GW Pharmaceuticals plc
                             ("GW" or "the Company")

                       Changes to Non-Executive Directors

GW Pharmaceuticals today announces the appointment of Mr David Morrison as a
non-executive director with immediate effect. Mr Morrison replaces Mr Peter
Mountford, who today resigns as a non-executive director.

David Morrison is Chief Executive of Prospect Investment Management, an
investment advisory firm. Clients of Prospect are shareholders in GW. David
began his career with 3i Group, followed by 13 years with Abingworth Management
Limited. David is also a non-executive director of a large number of public and
private companies, including Paypoint plc, Venture Production plc, BlueHeath
Holdings plc, MessageLabs Group Ltd, MGT plc, Standard Life Equity Investment
Trust plc and UK Specialist Hospitals Ltd.

Dr Geoffrey Guy, Executive Chairman of GW, said: "We are delighted to welcome
David to the Board of GW. David is a valued advisor to, and investor in, a range
of public and private companies and his expertise is ideally suited to GW as it
embarks on the next phase of its growth."

Commenting on the resignation of Peter Mountford, Dr Guy, said, "Peter has been
a non-executive director of GW for five years. Peter's extensive experience as
an investor in and advisor to emerging companies was instrumental in helping us
to successfully float on the AIM market in June 2001 and he has continued to be
a valuable member of the Board since that time. Everyone at GW joins me in
thanking Peter and wishing him all the best and continued success in his other
business ventures."

Peter Mountford owns warrants to subscribe for up to 51,765 ordinary shares in
the capital of the Company which originally expired on 14 January 2006. The
Board has agreed to extend the exercise period such that the warrants may be
exercised at any time on or before 14 January 2008.

                                    - Ends -

Enquiries:

GW Pharmaceuticals plc                                       + 44 (0)1980 557000
Dr Geoffrey Guy, Executive Chairman
Justin Gover, Managing Director

Weber Shandwick Square Mile                                 + 44 (0)20 7067 0700
Kevin Smith

Appendix

DAVID MORRISON - LIST OF CURRENT AND FORMER DIRECTORSHIPS

Current directorships:

UK Specialist Hospitals Limited
Shepton Mallet Treatment Centre Limited
Blueheath Holdings plc
Standard Life Equity Investment Trust plc
R.H.S. Enterprises Limited
Vibration Technology Limited
Luckington Properties Limited
MGt plc
MGt Trustee Limited
MessageLabs Group Limited
Venture Production plc
PayPoint plc
PayPoint Collections Limited
PayPoint Retails Solutions Limited
PayPoint Network Limited
The Houghton Club Limited
Prospect Investment Management Limited

Former directorships held since 8 February 2001:

Blue Heath Direct Limited
Arundel House Enterprises Limited

There are no further disclosures to be made in respect of David Morrison
pursuant to paragraph (f) of Schedule 2 of the AiM Rules for companies.





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOABRGDDRXGGGLC

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024